D'AMBROSIO, Lorenzo
D'AMBROSIO, Lorenzo
ONCOLOGIA
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study.
2012-01-01 Grignani G; Palmerini E; Dileo P; Asaftei SD; D'Ambrosio L; Pignochino Y; Mercuri M; Picci P; Fagioli F; Casali PG; Ferrari S; Aglietta M.
Abstract LB-366: Everolimus (EV) potentiates Sorafenib (SOR)activity in osteosarcoma (OS) preclinical models: a combination targeting the crosstalk between ERK1/2 and mTORC1/2 signaling pathways
2012-01-01 Pignochino, Y.; Dell'Aglio, C.; Basirico, M.; Capozzi, F.; Tarraran, L.; Soster, M.; Marchio, S.; Bruno, S.; Gammaitoni, L.; Sangiolo, D.; D'ambrosio, L.; Picci, P.; Aglietta, M.; Grignani, G.
Alpha-fetoprotein elevation in NUT midline carcinoma: a case report
2017-01-01 D'Ambrosio, Lorenzo; Palesandro, Erica; Moretti, Marina; Pelosi, Giuseppe; Fabbri, Alessandra; Carnevale Schianca, Fabrizio; Aglietta, Massimo; Grignani, Giovanni
Anticoagulation for central venous catheters in patients with cancer.
2014-01-01 D'Ambrosio L;Aglietta M;Grignani G
Assessment of morphological CT imaging features for the prediction of risk stratification, mutations, and prognosis of gastrointestinal stromal tumors
2021-01-01 Cannella R.; Tabone E.; Porrello G.; Cappello G.; Gozzo C.; Incorvaia L.; Grignani G.; Merlini A.; D'Ambrosio L.; Badalamenti G.; Regge D.; Bartolotta T.V.
CD44v6 as innovative sarcoma target for CAR-redirected CIK cells
2018-01-01 Leuci, V.; Casucci, G.M.; Grignani, G.; Rotolo, R.; Rossotti, U.; Vigna, E.; Gammaitoni, L.; Mesiano, G.; Fiorino, E.; Donini, C.; Pisacane, A.; ambrosio, L.D.; Pignochino, Y.; Aglietta, M.; Bondanza, A.; Sangiolo, D.
Complete remission of paraneoplastic vanishing bile duct syndrome after the successful treatment of Hodgkin's lymphoma: a case report and review of the literature.
2014-01-01 Rota Scalabrini D;Caravelli D;Carnevale Schianca F;D'Ambrosio L;Tolomeo F;Boccone P;Manca A;De Rosa G;Nuzzo A;Aglietta M;Grignani G
Complete Resolution of Life-Threatening Bleomycin-Induced Pneumonitis After Treatment With Imatinib Mesylate in a Patient With Hodgkin's Lymphoma: Hope for Severe Chemotherapy-Induced Toxicity?
2011-01-01 Carnevale-Schianca F; Gallo S; Rota-Scalabrini D; Sangiolo D; Fizzotti M; Caravelli D; Capaldi A; Anselmetti G; Palesandro E; D'Ambrosio L; Coha V; Obert R; Aglietta M; Grignani G.
CSPG4-specific CAR.CIK lymphocytes as a novel therapy for the treatment of multiple soft tissue sarcoma histotypes
2020-01-01 Leuci, Valeria; Donini, Chiara; Grignani, Giovanni; Rotolo, Ramona; Mesiano, Giulia; Fiorino, Erika; Gammaitoni, Loretta; D'Ambrosio, Lorenzo; Merlini, Alessandra; Landoni, Elisa; Medico, Enzo; Capellero, Sonia; Giraudo, Lidia; Cattaneo, Giulia; Iaia, Ilenia; Pignochino, Ymera; Basiricò, Marco; Vigna, Elisa; Pisacane, Alberto; Fagioli, Franca; Ferrone, Soldano; Aglietta, Massimo; Gianpietro, Dotti; Sangiolo, Dario
Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy
2018-01-01 Mesiano, Giulia; Grignani, Giovanni; Fiorino, Erika; Leuci, Valeria; Rotolo, Ramona; D'Ambrosio, Lorenzo; Salfi, Chiara; Gammaitoni, Loretta; Giraudo, Lidia; Pisacane, Alberto; Butera, Sara; Pignochino, Ymera; Basiricó, Marco; Capozzi, Federica; Sapino, Anna; Aglietta, Massimo; Sangiolo, Dario
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas.
2014-01-01 Sangiolo D; Mesiano G; Gammaitoni L; Leuci V; Todorovic M; Giraudo L; Cammarata C; Dell'aglio C; D'Ambrosio L; Pisacane A; Sarotto I; Miano S; Ferrero I; Carnevale-Schianca F; Pignochino Y; Sassi F; Bertotti A; Piacibello W; Fagioli F; Aglietta M; Grignani G.
Delving into PARP inhibition from bench to bedside and back
2020-01-01 Grignani G.; Merlini A.; Sangiolo D.; D'Ambrosio L.; Pignochino Y.
DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination
2022-01-01 Alessandra Merlini, Maria Laura Centomo, Giulio Ferrero, Giulia Chiabotto, Umberto Miglio,Enrico Berrino, Giorgia Giordano, Silvia Brusco, Alberto Pisacane, Elena Maldi, Ivana Sarotto,Federica Capozzi, Cristina Lano, Claudio Isella, Giovanni Crisafulli, Massimo Aglietta,Angelo Paolo Dei Tos, Marta Sbaraglia,Dario Sangiolo, Lorenzo D’Ambrosio, Alberto Bardelli, Ymera Pignochino, Giovanni Grignani
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
2020-01-01 D'Ambrosio, Lorenzo; Touati, Nathan; Blay, Jean-Yves; Grignani, Giovanni; Flippot, Ronan; Czarnecka, Anna M; Piperno-Neumann, Sophie; Martin-Broto, Javier; Sanfilippo, Roberta; Katz, Daniela; Duffaud, Florence; Vincenzi, Bruno; Stark, Daniel P; Mazzeo, Filomena; Tuchscherer, Armin; Chevreau, Christine; Sherriff, Jenny; Estival, Anna; Litière, Saskia; Sents, Ward; Ray-Coquard, Isabelle; Tolomeo, Francesco; Le Cesne, Axel; Rutkowski, Piotr; Stacchiotti, Silvia; Kasper, Bernd; Gelderblom, Hans; Gronchi, Alessandro
Efficacy thresholds for clinical trials with advanced or metastatic leiomyosarcoma patients: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group meta-analysis based on a literature review for soft-tissue sarcomas
2021-01-01 Kantidakis, Georgios; Litière, Saskia; Neven, Anouk; Vinches, Marie; Judson, Ian; Schöffski, Patrick; Wardelmann, Eva; Stacchiotti, Silvia; D'Ambrosio, Lorenzo; Marréaud, Sandrine; van der Graaf, Winette T A; Kasper, Bernd; Fiocco, Marta; Gelderblom, Hans
Epha2 expression in bone sarcomas: Bioinformatic analyses and preclinical characterization in patient-derived models of osteosarcoma, ewing’s sarcoma and chondrosarcoma
2021-01-01 Giordano G.; Merlini A.; Ferrero G.; Mesiano G.; Fiorino E.; Brusco S.; Centomo M.L.; Leuci V.; D'ambrosio L.; Aglietta M.; Sangiolo D.; Grignani G.; Pignochino Y.
Eribulin-based treatment in patients affected by sarcomas: a case series
2020-01-01 Grignani, Giovanni; D'Ambrosio, Lorenzo
Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients
2017-01-01 Longhi, A; Bielack, S S; Grimer, R; Whelan, J; Windhager, R; Leithner, A; Gronchi, A; Biau, D; Jutte, P; Krieg, A H; Klenke, F M; Grignani, G; Donati, D M; Capanna, R; Casanova, J; Gerrand, C; Bisogno, G; Hecker-Nolting, S; De Lisa, M; D'Ambrosio, L; Willegger, M; Scoccianti, G; Ferrari, S
First and further-line multidisciplinary treatment of retroperitoneal sarcomas
2022-01-01 D'Ambrosio, Lorenzo; Van Houdt, Winan; Stelmes, Jean-Jacques; Gronchi, Alessandro
High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series
2020-01-01 Palmerini E.; Setola E.; Grignani G.; D'Ambrosio L.; Comandone A.; Righi A.; Longhi A.; Cesari M.; Paioli A.; Hakim R.; Pierini M.; Marchesi E.; Vanel D.; Pignochino Y.; Donati D.M.; Picci P.; Ferrari S.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study. | 2012 | Grignani G; Palmerini E; Dileo P; Asaftei SD; D'Ambrosio L; Pignochino Y; Mercuri M; Picci P; Fagioli F; Casali PG; Ferrari S; Aglietta M. | |
| Abstract LB-366: Everolimus (EV) potentiates Sorafenib (SOR)activity in osteosarcoma (OS) preclinical models: a combination targeting the crosstalk between ERK1/2 and mTORC1/2 signaling pathways | 2012 | Pignochino, Y.; Dell'Aglio, C.; Basirico, M.; Capozzi, F.; Tarraran, L.; Soster, M.; Marchio, S.; Bruno, S.; Gammaitoni, L.; Sangiolo, D.; D'ambrosio, L.; Picci, P.; Aglietta, M.; Grignani, G. | |
| Alpha-fetoprotein elevation in NUT midline carcinoma: a case report | 2017 | D'Ambrosio, Lorenzo; Palesandro, Erica; Moretti, Marina; Pelosi, Giuseppe; Fabbri, Alessandra; Carnevale Schianca, Fabrizio; Aglietta, Massimo; Grignani, Giovanni | |
| Anticoagulation for central venous catheters in patients with cancer. | 2014 | D'Ambrosio L;Aglietta M;Grignani G | |
| Assessment of morphological CT imaging features for the prediction of risk stratification, mutations, and prognosis of gastrointestinal stromal tumors | 2021 | Cannella R.; Tabone E.; Porrello G.; Cappello G.; Gozzo C.; Incorvaia L.; Grignani G.; Merlini A.; D'Ambrosio L.; Badalamenti G.; Regge D.; Bartolotta T.V. | |
| CD44v6 as innovative sarcoma target for CAR-redirected CIK cells | 2018 | Leuci, V.; Casucci, G.M.; Grignani, G.; Rotolo, R.; Rossotti, U.; Vigna, E.; Gammaitoni, L.; Mesiano, G.; Fiorino, E.; Donini, C.; Pisacane, A.; ambrosio, L.D.; Pignochino, Y.; Aglietta, M.; Bondanza, A.; Sangiolo, D. | |
| Complete remission of paraneoplastic vanishing bile duct syndrome after the successful treatment of Hodgkin's lymphoma: a case report and review of the literature. | 2014 | Rota Scalabrini D;Caravelli D;Carnevale Schianca F;D'Ambrosio L;Tolomeo F;Boccone P;Manca A;De Rosa G;Nuzzo A;Aglietta M;Grignani G | |
| Complete Resolution of Life-Threatening Bleomycin-Induced Pneumonitis After Treatment With Imatinib Mesylate in a Patient With Hodgkin's Lymphoma: Hope for Severe Chemotherapy-Induced Toxicity? | 2011 | Carnevale-Schianca F; Gallo S; Rota-Scalabrini D; Sangiolo D; Fizzotti M; Caravelli D; Capaldi A; Anselmetti G; Palesandro E; D'Ambrosio L; Coha V; Obert R; Aglietta M; Grignani G. | |
| CSPG4-specific CAR.CIK lymphocytes as a novel therapy for the treatment of multiple soft tissue sarcoma histotypes | 2020 | Leuci, Valeria; Donini, Chiara; Grignani, Giovanni; Rotolo, Ramona; Mesiano, Giulia; Fiorino, Erika; Gammaitoni, Loretta; D'Ambrosio, Lorenzo; Merlini, Alessandra; Landoni, Elisa; Medico, Enzo; Capellero, Sonia; Giraudo, Lidia; Cattaneo, Giulia; Iaia, Ilenia; Pignochino, Ymera; Basiricò, Marco; Vigna, Elisa; Pisacane, Alberto; Fagioli, Franca; Ferrone, Soldano; Aglietta, Massimo; Gianpietro, Dotti; Sangiolo, Dario | |
| Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy | 2018 | Mesiano, Giulia; Grignani, Giovanni; Fiorino, Erika; Leuci, Valeria; Rotolo, Ramona; D'Ambrosio, Lorenzo; Salfi, Chiara; Gammaitoni, Loretta; Giraudo, Lidia; Pisacane, Alberto; Butera, Sara; Pignochino, Ymera; Basiricó, Marco; Capozzi, Federica; Sapino, Anna; Aglietta, Massimo; Sangiolo, Dario | |
| Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas. | 2014 | Sangiolo D; Mesiano G; Gammaitoni L; Leuci V; Todorovic M; Giraudo L; Cammarata C; Dell'aglio C; D'Ambrosio L; Pisacane A; Sarotto I; Miano S; Ferrero I; Carnevale-Schianca F; Pignochino Y; Sassi F; Bertotti A; Piacibello W; Fagioli F; Aglietta M; Grignani G. | |
| Delving into PARP inhibition from bench to bedside and back | 2020 | Grignani G.; Merlini A.; Sangiolo D.; D'Ambrosio L.; Pignochino Y. | |
| DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination | 2022 | Alessandra Merlini, Maria Laura Centomo, Giulio Ferrero, Giulia Chiabotto, Umberto Miglio,Enrico Berrino, Giorgia Giordano, Silvia Brusco, Alberto Pisacane, Elena Maldi, Ivana Sarotto,Federica Capozzi, Cristina Lano, Claudio Isella, Giovanni Crisafulli, Massimo Aglietta,Angelo Paolo Dei Tos, Marta Sbaraglia,Dario Sangiolo, Lorenzo D’Ambrosio, Alberto Bardelli, Ymera Pignochino, Giovanni Grignani | |
| Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group | 2020 | D'Ambrosio, Lorenzo; Touati, Nathan; Blay, Jean-Yves; Grignani, Giovanni; Flippot, Ronan; Czarnecka, Anna M; Piperno-Neumann, Sophie; Martin-Broto, Javier; Sanfilippo, Roberta; Katz, Daniela; Duffaud, Florence; Vincenzi, Bruno; Stark, Daniel P; Mazzeo, Filomena; Tuchscherer, Armin; Chevreau, Christine; Sherriff, Jenny; Estival, Anna; Litière, Saskia; Sents, Ward; Ray-Coquard, Isabelle; Tolomeo, Francesco; Le Cesne, Axel; Rutkowski, Piotr; Stacchiotti, Silvia; Kasper, Bernd; Gelderblom, Hans; Gronchi, Alessandro | |
| Efficacy thresholds for clinical trials with advanced or metastatic leiomyosarcoma patients: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group meta-analysis based on a literature review for soft-tissue sarcomas | 2021 | Kantidakis, Georgios; Litière, Saskia; Neven, Anouk; Vinches, Marie; Judson, Ian; Schöffski, Patrick; Wardelmann, Eva; Stacchiotti, Silvia; D'Ambrosio, Lorenzo; Marréaud, Sandrine; van der Graaf, Winette T A; Kasper, Bernd; Fiocco, Marta; Gelderblom, Hans | |
| Epha2 expression in bone sarcomas: Bioinformatic analyses and preclinical characterization in patient-derived models of osteosarcoma, ewing’s sarcoma and chondrosarcoma | 2021 | Giordano G.; Merlini A.; Ferrero G.; Mesiano G.; Fiorino E.; Brusco S.; Centomo M.L.; Leuci V.; D'ambrosio L.; Aglietta M.; Sangiolo D.; Grignani G.; Pignochino Y. | |
| Eribulin-based treatment in patients affected by sarcomas: a case series | 2020 | Grignani, Giovanni; D'Ambrosio, Lorenzo | |
| Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients | 2017 | Longhi, A; Bielack, S S; Grimer, R; Whelan, J; Windhager, R; Leithner, A; Gronchi, A; Biau, D; Jutte, P; Krieg, A H; Klenke, F M; Grignani, G; Donati, D M; Capanna, R; Casanova, J; Gerrand, C; Bisogno, G; Hecker-Nolting, S; De Lisa, M; D'Ambrosio, L; Willegger, M; Scoccianti, G; Ferrari, S | |
| First and further-line multidisciplinary treatment of retroperitoneal sarcomas | 2022 | D'Ambrosio, Lorenzo; Van Houdt, Winan; Stelmes, Jean-Jacques; Gronchi, Alessandro | |
| High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series | 2020 | Palmerini E.; Setola E.; Grignani G.; D'Ambrosio L.; Comandone A.; Righi A.; Longhi A.; Cesari M.; Paioli A.; Hakim R.; Pierini M.; Marchesi E.; Vanel D.; Pignochino Y.; Donati D.M.; Picci P.; Ferrari S. |